CardioFocus

CardioFocus, Inc. is a medical device manufacturer dedicated to advancing ablation treatment for cardiac disorders such as AFib.

[CardioFocus @CardioFocusAF]

At #AFSymposium2026, QuickShot™ Nav demonstrated magnetic integration with LUMA Vision’s VERAFEYE™ system, enabling precise, real-time visualization and navigation during PFA.

Note: QuickShot™ Nav is investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

AF Symposium 2026 is here and CardioFocus is energized to be on the ground in Boston with our team!

📍Global IDE site recruitment in our tech suite (MR11)
🧬Late-breaking presentation tonight at 5:10 PM by Dr. Vivek Reddy on VISION AF first-in-human data

#EPeeps #AFS2026 #PFA

[CardioFocus @CardioFocusAF]

AF Symposium 2026 starts this week—and CardioFocus is bringing new data, new studies, and a growing PFA portfolio to Boston!⚡

🔗Read the full press release: https://t.co/XHAVdfm7Vs..
📍Visit us at our Tech Suite MR11

#EPeeps #AFSymposium2026

[CardioFocus @CardioFocusAF]

Congrats to St. Anne's University Hospital Brno for their first cases in the CardioFocus CE Mark pivotal trial evaluating the QuickShot™ Nav PFA Catheter & CardioWave™ PFA System.

QuickShot™ Nav and CardioWave™ are investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

Excited to have enrolled the first patients at Nemocnice Na Homolce in our CE Mark pivotal trial of the QuickShot™ Nav PFA Catheter and CardioWave™ PFA System.

Note: The QuickShot™ Nav and CardioWave™ are investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

We’re thrilled to share major milestones: the launch and first patient enrollments in our CE Mark pivotal trial for the QuickShot™ Nav large-area focal PFA Catheter and the next-generation CardioWave™ PFA System.

Read more: https://t.co/idRnFSCqei

[CardioFocus @CardioFocusAF]

Yesterday in Boston, we had the privilege of hosting another Physician Advisory Board Meeting �� bringing together some brilliant minds to dive deeper into our #PFA portfolio. Hands-on sessions and collaborative discussions made it a truly productive day.

[CardioFocus @CardioFocusAF]

What an incredible day in Prague at one of our first Physician Advisory Board Meetings! A huge thank you to all the distinguished electrophysiologists for sharing your expertise during the discussions and hands-on sessions with our #PFA portfolio.

[CardioFocus @CardioFocusAF]

We were proud to share a live OptiShot™ PFA Balloon case from our ongoing VISION-AF trial at #FAFA2025. Thank you to Drs Petr Neuzil and Moritoshi Funasako for leading a great case.

Note: The OptiShot™ PFA Balloon System is investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

#BigNews: Proud to announce our partnership with BIOTRONIK — a collaboration that will expand access to the Centauri™ PFA System across 17 European countries!

🔗Full press release: https://t.co/gutsAwmPe1

Note: The Centauri system is not approved for sale in the United States.

[CardioFocus @CardioFocusAF]

A New Wave of Independent Centauri Data in EP Europace! Explore the research:

🔗https://t.co/nrqpL0rRtl
🔗https://t.co/y3LHDAOeQW
🔗https://t.co/RoKQF2lm7B
🔗https://t.co/WN9GIM85EY
🔗https://t.co/KPSU3HIM8a
🔗https://t.co/piqZ7nzgpP

#epeeps

[CardioFocus @CardioFocusAF]

Another day, another successful live #PFA case at Prague Rhythm 2025 — marking the first clinical showcase of our QuickShot™ Nav catheter by Dr. Ante Anic and the stellar team at KBC Split (Croatia).

Note: QuickShot™ Nav is investigational and not approved for commercial use

[CardioFocus @CardioFocusAF]

Today’s OptiShot™ live PFA case at Prague Rhythm 2025 delivered on all fronts!

Huge thanks to Dr. Vivek Reddy for a great case demonstration.

Note: The OptiShot™ PFA Balloon System is investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

CardioFocus is LIVE at Prague Rhythm 2025!

🔗See our full schedule below to plan your sessions.

Note: The OptiShot™ PFA Balloon System and QuickShot™ Nav are investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

Big thanks to Dr. Ante Anić for spotlighting CardioFocus’ Centauri PFA system at the CSI webinar! He discussed lesion depths up to 8.2 mm with no thermal effects, enabled by our proprietary Wave1™ waveform.

Note: The Centauri system is not approved for sale in the United States

[CardioFocus @CardioFocusAF]

⚡#HRS2025 week is off to a strong start! Catch the CardioFocus PFA highlights so far➡️

Note: The OptiShot™ PFA Balloon System is investigational and not approved for commercial use.

[CardioFocus @CardioFocusAF]

CardioFocus is headed to #HRS2025 in San Diego this week!

📍 Booth 1328
🔬 Tech Suite TS855

🔗 Don’t miss our full HRS press release: https://t.co/PGPucUyglX

#HRS2025 #epeeps #AFib #PFA

[CardioFocus @CardioFocusAF]

#MilestoneAlert: CardioFocus just completed successful clinical cases with QuickShot™ Nav, our large-area focal PFA catheter, as part of the Quick AF trial.

📢 Read more: https://t.co/iQaBRby493

#PFA #QuickShotPFA #Epeeps #AFib

[CardioFocus @CardioFocusAF]

📍Live from #EHRA2025! Clinical interest in Centauri's Focal PFA is stronger than ever. If you haven’t connected with us yet, stop by Booth A700 to learn more about its real-world impact!

#epeeps #AFib #PFA

Note: Centauri is not approved for sale in the United States.

[CardioFocus @CardioFocusAF]

CardioFocus is proud to be a sponsor of PFA 101: From Bench to Bedside, a complimentary CME program designed to provide a comprehensive understanding of Pulsed Field Ablation (PFA) ahead of #EHRA2025.

📍 This Friday, March 28, 2025 | Hilton Vienna Danube Waterfront